Traders increased their bets on the Fed's interest rate cut. After the CPI report was released, swap traders increased their bets on the Fed's interest rate cut before the end of 2025. They now predict that by that time, they will cut interest rates by 87 basis points, which means that the Federal Reserve will cut interest rates by 25 basis points next week. In 2025, there will be another two interest rate cuts of 25 basis points each time, which is less than the four times proposed by Fed officials in the latest quarterly bitmap in September.Huichuan Technology: Small-load six-axis robots have been sold in large quantities, and large-load six-axis robots have begun to be sold in large quantities. Huichuan Technology said on the interactive platform that the company has greatly expanded the products and applications of six-axis robots, and the small-load six-axis robots have been sold in large quantities, and the large-load six-axis robots have begun to form mass sales.Jinfei Kaida: The controlling shareholder plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinfei Kaida (002863) announced on the evening of December 11th that the controlling shareholder Jinfei Holdings plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinhua Branch of China Construction Bank Co., Ltd. issued the "China Construction Bank Loan Commitment Letter" to Jinfei Holdings on December 10th, promising to provide Jinfei Holdings with a special loan of no more than 90 million yuan for stock increase, with a loan period of 3 years.
Huichuan Technology: Small-load six-axis robots have been sold in large quantities, and large-load six-axis robots have begun to be sold in large quantities. Huichuan Technology said on the interactive platform that the company has greatly expanded the products and applications of six-axis robots, and the small-load six-axis robots have been sold in large quantities, and the large-load six-axis robots have begun to form mass sales.In November, Sichuan CPI rose by 0.1% year-on-year, and the price increase of pork and fresh vegetables dropped from the previous month. On December 10, the data released by the Sichuan Survey Corps of the National Bureau of Statistics showed that the consumer price index (CPI) in Sichuan rose by 0.1% year-on-year, and the growth rate dropped by 0.1 percentage point from the previous month. It decreased by 0.7% from the previous month. From January to November, the consumer price of Sichuan residents decreased by 0.1% compared with the same period of last year. In terms of food, the price of food, tobacco and alcohol rose by 1.8% year-on-year in November, and the growth rate dropped by 1.1 percentage points from the previous month. Among them, the prices of pork and fresh vegetables increased by 15.2% and 14.0% year-on-year, respectively, and the growth rate dropped from last month; The price of fresh fruit changed from a year-on-year increase of 3.4% last month to an increase of 2.0%; The prices of eggs and aquatic products decreased by 1.6% and 0.6% respectively. From the ring comparison, the price of food, tobacco and alcohol decreased by 1.9% from 0.3% last month, mainly because the average temperature in November was higher than that in previous years, which was beneficial to the production, storage and transportation of agricultural products, and most fresh food prices were affected by the super-seasonal decline.AIA: It cost about HK$ 62.73 million to buy back nearly 1.07 million shares. AIA Holdings Limited announced that it spent about HK$ 62.73 million to buy back about 1.07 million shares that day, accounting for 0.0098% of the issued shares, and the repurchase price per share ranged from HK$ 563,84942 to HK$ 598,0954.
MERO, the Czech pipeline operator: The oil transportation to the Czech Republic through the "Friendship" pipeline continues to run as planned.CITIC Bank: Redemption of open-ended capital bonds. CITIC Bank announced that from December 9 to December 11, 2019, it issued RMB 40 billion of open-ended capital bonds (hereinafter referred to as "current bonds"), and on December 12, 2019, it issued the Announcement of China CITIC Bank Corporation on the Completion of Issuance of Open-ended Capital Bonds. According to the relevant provisions of the prospectus of this issue, this issue has the issuer's conditional redemption right, and the issuer has the right to redeem this issue in whole or in part on the interest payment date of the fifth year of this issue, that is, December 11, 2024. As of the date of this announcement, with the approval of the State Financial Supervision and Administration, the Bank has exercised the right of redemption and redeemed the bonds in full.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14